Guardant Health (GH) Receivables - Net (2017 - 2025)
Guardant Health (GH) has disclosed Receivables - Net for 9 consecutive years, with $137.8 million as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 25.03% to $137.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $137.8 million through Dec 2025, up 25.03% year-over-year, with the annual reading at $137.8 million for FY2025, 25.03% up from the prior year.
- Receivables - Net hit $137.8 million in Q4 2025 for Guardant Health, up from $115.6 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $137.8 million in Q4 2025 to a low of $48.0 million in Q1 2021.
- Historically, Receivables - Net has averaged $92.9 million across 5 years, with a median of $88.8 million in 2023.
- Biggest five-year swings in Receivables - Net: surged 83.22% in 2021 and later dropped 9.24% in 2023.
- Year by year, Receivables - Net stood at $97.7 million in 2021, then decreased by 0.41% to $97.3 million in 2022, then decreased by 8.71% to $88.8 million in 2023, then increased by 24.18% to $110.3 million in 2024, then grew by 25.03% to $137.8 million in 2025.
- Business Quant data shows Receivables - Net for GH at $137.8 million in Q4 2025, $115.6 million in Q3 2025, and $130.3 million in Q2 2025.